Centene Corp (CNC · NYSE)
CNC · MARKET VIEW
Market view · as of Oct 5, 2026
Price (last ~year)
Centene shares rose 3.3% to $62.99 after Q2 adjusted EPS of $2.51 crushed the $0.89 estimate, its fourth straight beat, and management raised full-year 2026 guidance. The quarter showed a sharp recovery from the losses reported in the two prior quarters (net income of -$6.63B in Q3 2025 and -$1.10B in Q4 2025), with Q2 revenue of $44.38B and trailing-twelve-month revenue of $180.30B, up 4.6% year over year. The stock remains down 7.4% over the past month and carries an RSI of 27, though it sits 19.3% above its 200-day average and 82.9% of its 52-week range. Leverage is moderate at 3.5x debt/EBITDA with $24.15B in cash, and the company generated $4.20B in free cash flow in the quarter.
Valuation
- Market cap
- $31.12B
- PEG
- 0.748
- P/B
- 1.359
- P/S
- 0.173
- EV/EBITDA
- 3.91
- Beta
- 1.106
- Analyst target
- $71.78
Quality & returns
- Gross margin
- 11.4%
- Operating margin
- 3.8%
- Profit margin
- -2.8%
- ROE
- -20.4%
- ROA
- 2.5%
Price movement
- Last
- $62.99
- 1-month
- -7.4%
- 3-month
- -6.8%
- RSI (14)
- 27
- vs SMA200
- +19.3%
- 52-wk position
- 82.9% -9.2% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $44.38B | $1.38B | $1.09B | $1.78B |
| 2026-03-31 | $49.94B | $1.86B | $1.54B | $2.56B |
| 2025-12-31 | $49.73B | $-1.74B | $-1.10B | $-1.05B |
| 2025-09-30 | $49.69B | $-6.95B | $-6.63B | $-6.19B |
Recent news
- Somewhat-Bullish Centene Corp. stock pre-market at EUR 56.34: plus 0.64 percent · 2026-10-05
- Bullish Centene stock gained 3.28 percent as earnings recovery took hold · 2026-10-04
- Bullish Centene Corp stock gains 3.28 percent as earnings outlook improves · 2026-10-03
- Somewhat-Bullish UnitedHealth Reports on Oct. 13. Here's the 1 Number I'm Watching. · 2026-10-03
- Somewhat-Bullish Centene Corp (CNC) Stock Up 3.3% and Still Undervalued -- GF Sco · 2026-10-02
- Somewhat-Bearish UnitedHealth and Humana cutting Medicare Advantage plans in 2027 · 2026-10-02
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)